ADIPOQ and obesity disorder: The adipocyte secretion-associated alteration in obesity, including the changes in the ratio of leptin to adiponectin, the expression levels of pro-inflammatory cytokines, IGFs, and estrogen, may be the mechanisms potentially leading to BC immunotherapy resistance.